Phoenix Molecular Designs
  • About US Mission & Vision Management Team Board of Directors Advisory Board
  • Science Precision Medicine Scientific Posters Publications
  • Pipeline
  • Media Latest News
  • About Trial Details
  • Patient Resources
  • Contact
Phoenix Molecular Designs
  • About/
    • About US
    • Mission & Vision
    • Management Team
    • Board of Directors
    • Advisory Board
  • Our Science/
    • Science
    • Precision Medicine
    • Scientific Posters
    • Publications
  • Pipeline/
  • Investors & media/
    • Media
    • Latest News
  • Phase 2 Clinical Trial/
    • About
    • Trial Details
  • Patient Resources/
  • Contact/
tubes_red Watermarked.jpg
Phoenix Molecular Designs

Personalized and alternative cancer therapeutics for quality of life

Media

Phoenix Molecular Designs
  • About/
    • About US
    • Mission & Vision
    • Management Team
    • Board of Directors
    • Advisory Board
  • Our Science/
    • Science
    • Precision Medicine
    • Scientific Posters
    • Publications
  • Pipeline/
  • Investors & media/
    • Media
    • Latest News
  • Phase 2 Clinical Trial/
    • About
    • Trial Details
  • Patient Resources/
  • Contact/
December 11, 2013

Groundbreaking research in triple-negative breast cancer provides hope

December 11, 2013/ Guest User

December 11, 2013 - The National Post features Dr. Sandra Dunn and her research team's breakthrough discovery in targeting triple-negative breast cancer.

Read the full story here...

December 11, 2013/ Guest User/

Guest User

  • A Day for Science and Compassion: ...
  • Exploring Alcoholism Drug’s ...
Contact us

2024© Phoenix Molecular Designs